SUCCESSFUL MANAGEMENT OF PERIPARTUM CARDIOMYOPATHY IN A YOUNG FEMALE PATIENT
Abstract
Keywords
References
- 1. Koenig T, Hilfiker-Kleiner D, Bauersachs J. Peripartum cardiomyopathy. Herz 2018;43(5):431-7.
- 2. Sliwa K, Hilfiker-Kleiner D, Petrie MC et al. Current state of knowledge on ae- tiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12(8):767-78.
- 3. Garg J, Palaniswamy C, Lanier GM. Peripartum cardiomyopathy: definition, inci- dence, etiopathogenesis, diagnosis, and management. Cardiol Rev 2015;23(2):69- 78.
- 4. Yamac H, Bultmann I, Sliwa K et al. Prolactin: a new therapeutic target in peripar- tum cardiomyopathy. Heart 2010;96(17):1352-7.
- 5. Abboud J, Murad Y, Chen-Scarabelli C et al. Peripartum cardiomyopathy: a com- prehensive review. Int J Cardiol 2007;118(3):295-303.
- 6. Baris L, Cornette J, Johnson MR et al. Peripartum cardiomyopathy: disease or syndrome? Heart 2019;105(5):357-62.
- 7. Ballo P, Betti I, Mangialavori G et al. Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine. Case Rep Med 2012 Nov 22. doi: 10.1155/2012/476903. [Epub ahead of print]
- 8. Arrigo M, Blet A, Mebazaa A. Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD. Eur Heart J 2017;38(35):2680-2.
Details
Primary Language
English
Subjects
Clinical Sciences
Journal Section
Case Report
Authors
Ceren Yüksel
*
This is me
0000-0003-2456-7282
Türkiye
Bengisu Çıray
This is me
0000-0001-6332-7543
Türkiye
Mustafa Alperen Koşucu
This is me
0000-0002-2381-5099
Türkiye
Servet Altay
This is me
0000-0001-7112-3970
Türkiye
Publication Date
October 1, 2021
Submission Date
August 14, 2021
Acceptance Date
August 28, 2021
Published in Issue
Year 2021 Volume: 8 Number: 3